Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk

Introduction. Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk. We have further analyzed the role of diabetes and antidiabetic treatments on HCC. Methods. Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC pati...

Full description

Bibliographic Details
Main Authors:	Luca Miele, Cristina Bosetti, Federica Turati, Gianlodovico Rapaccini, Antonio Gasbarrini, Carlo La Vecchia, Stefania Boccia, Antonio Grieco
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2015/570356

Similar Items

The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma
by: Stefania Boccia, et al.
Published: (2015-01-01)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01)

Metformin versus insulin in the management of gestational diabetes mellitus
by: Ola Amer Mahmood
Published: (2019-01-01)

TREATMENT OF THE TYPE 2 OF DIABETES PATIENTS WITH THE SECONDARY FAILURE OF THE ORAL THERAPY: COMPARISON OF THE INSULIN-SULFONYLUREA REGIME AND THAT OF THE INSULIN-METFORMIN
by: Saša Živić, et al.
Published: (2002-09-01)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
by: Maria Mirabelli, et al.
Published: (2021-03-01)

The effect of combination therapy of insulin glargine, metformin, and sitagliptin on insulin secretion, insulin resistance, and metabolic parameters in obese subjects with type 2 diabetes
by: Beljić-Živković Teodora, et al.
Published: (2016-01-01)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
by: Hend S. Saleh, et al.
Published: (2016-01-01)

Prevention of deterioration of bone microarchitectonics with metformin in diabetes with insulin deficiency
Published: (2013-10-01)

Diabetes, pancreatic cancer, and metformin therapy
by: Jun eGong, et al.
Published: (2014-11-01)

The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
by: Katsiaryna Sikorskaya, BSN, RN, CSN, et al.
Published: (2021-03-01)

Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
by: Victor Cunha, et al.
Published: (2020-05-01)

Cancer mortality in Latin America: implications for prevention
by: Cristina Bosetti, et al.
Published: (2005-07-01)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
by: Marta Seghieri, et al.
Published: (2018-08-01)

Effect of metformin on insulin resistance
by: Si-Yu Young, et al.
Published: (2004)

The effect and estimate by using thiazolidinediones、 Metformin、Sulfonylureas and Insulin for diabetes’s complication
by: Te-Lung Chien, et al.
Published: (2005)

Metformin vs insulin in the management of gestational diabetes: a meta-analysis.
by: Juan Gui, et al.
Published: (2013-01-01)

Effects Of Metformin In Insulin – Treated Type 2 Diabetes Mellitus Patients
by: Nakhjavani M, et al.
Published: (2005-06-01)

The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellits Type 2 in the Early Stage of the Disease
by: Emela Mujić-Skikić, et al.
Published: (2008-08-01)

The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellits Type 2 in the Early Stage of the Disease
by: Belma Aščić - Buturović
Published: (2006-05-01)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01)

Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells.
by: Tomoko Saito, et al.
Published: (2013-01-01)

Difference of changes in total and triglyseride cholesterol levels of insulin monotherapy use with combination insulin and metformin therapy in type II diabetes mellitus patients
by: Prita Murani Nugraheti, et al.
Published: (2019-04-01)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
by: Gebrie D, et al.
Published: (2021-07-01)

A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models
by: Mengsiyu Li, et al.
Published: (2019-01-01)

Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
by: Mieczkowski M, et al.
Published: (2021-04-01)

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
by: Christian Stevns Hansen, et al.
Published: (2020-09-01)

Glycemic Index, Glycemic Load and Cancer Risk: An Updated Meta-Analysis
by: Federica Turati, et al.
Published: (2019-10-01)

Metformin: A Bridge between Diabetes and Prostate Cancer
by: Veronica Zingales, et al.
Published: (2017-10-01)

The Influence of Metformin Brand Shift by Hospital on Diabetic Therapy
by: Hui-Yin Chen, et al.
Published: (2009)

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
by: Alfredo Papa, et al.
Published: (2020-07-01)

Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes.
by: Isabel Garcia-Martin, et al.
Published: (2018-01-01)

Metformin or insulin: logical treatment in women with gestational diabetes in the Middle East, our experience
by: Sindu J. Christian, et al.
Published: (2018-07-01)

Recurrent impetigo herpetiformis with diabetes and hypoalbuminemia successfully treated with cyclosporine, albumin, insulin and metformin
by: Lakshmi Chembolli, et al.
Published: (2010-01-01)

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.
by: Monica Franciosi, et al.
Published: (2013-01-01)

Metformin poisoning treated with high dose insulin dextrose therapy: a case series
by: Theodore Young, et al.
Published: (2019-05-01)

Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.
by: Wei-Ru Cho, et al.
Published: (2021-01-01)

Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats
by: Maysa A. Mobasher, et al.
Published: (2021-01-01)

Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity
by: Antonio Carlo Bossi, et al.
Published: (2020-04-01)

Immune Checkpoint Inhibitor Induced Diabetes Mellitus Treated with Insulin and Metformin: Evolution of Diabetes Management in the Era of Immunotherapy
by: Taha Alrifai, et al.
Published: (2019-01-01)

Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility)
by: M.Yu. Horshunskaia
Published: (2015-05-01)

Cannot write session to /tmp/vufind_sessions/sess_41agbu4af8l8t9u0k8o421dnil